Literature DB >> 8752180

E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.

G Mbalaviele1, C R Dunstan, A Sasaki, P J Williams, G R Mundy, T Yoneda.   

Abstract

The molecular mechanisms by which human cancer cells spread to bone are largely unexplored. The process likely involves cell adhesion molecules (CAMs) that are responsible for homophilic and heterophilic cell-cell interactions. One relevant CAM may be the calcium-dependent transmembrane glycoprotein E-cadherin. To investigate the involvement of E-cadherin in breast cancer metastasis to bone, we used an in vivo model in which osteolytic bone metastases preferentially occur after injections of cancer cells directly into the arterial circulation through the left ventricle of the hearts of nude mice. We have found that E-cadherin-negative human breast cancer cells MDA-MB-231 (MDA-231) develop radiographically detectable multiple osteolytic bone metastases and cachexia in this model. However, MDA-231 breast cancer cells that were transfected with E-cadherin cDNA showed a dramatically impaired capacity to form osteolytic metastases and induce cachexia. Histological and histomorphometrical analyses of bones of mice bearing mock-transfected MDA-231 revealed aggressive metastatic tumor, whereas metastatic tumor burden was significantly decreased in the bones of mice bearing E-cadherin-expressing MDA-231. Nude mice bearing E-cadherin-transfected MDA-231 breast cancer cells survived longer than mice bearing mock-transfected MDA-231 breast cancer cells. Anchorage-dependent and -independent growth in culture and tumor enlargement in the mammary fat pad of nude mice were unchanged between mock-transfected and E-cadherin-expressing MDA-231, suggesting that these differences in metastatic behavior are not due to an impairment of cell growth and tumor-igenicity. Our results show the suppressive effects of E-cadherin expression on bone metastasis by circulating breast cancer cells and suggest that the modulation of expression of this CAM may reduce the destructive effects of breast cancer cells on bone.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8752180

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  54 in total

1.  E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors.

Authors:  M Y Hsu; F E Meier; M Nesbit; J Y Hsu; P Van Belle; D E Elder; M Herlyn
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

2.  Analysis of mechanisms underlying BRMS1 suppression of metastasis.

Authors:  R S Samant; M J Seraj; M M Saunders; T S Sakamaki; L A Shevde; J F Harms; T O Leonard; S F Goldberg; L Budgeon; W J Meehan; C R Winter; N D Christensen; M F Verderame; H J Donahue; D R Welch
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 3.  Cadherin junctions in mammary tumors.

Authors:  M J Wheelock; A P Soler; K A Knudsen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.673

4.  Bone-derived IGF mediates crosstalk between bone and breast cancer cells in bony metastases.

Authors:  Toru Hiraga; Akira Myoui; Nobuyuki Hashimoto; Akira Sasaki; Kenji Hata; Yoshihiro Morita; Hideki Yoshikawa; Clifford J Rosen; Gregory R Mundy; Toshiyuki Yoneda
Journal:  Cancer Res       Date:  2012-06-27       Impact factor: 12.701

5.  Targeting energy metabolic and oncogenic signaling pathways in triple-negative breast cancer by a novel adenosine monophosphate-activated protein kinase (AMPK) activator.

Authors:  Kuen-Haur Lee; En-Chi Hsu; Jih-Hwa Guh; Hsiao-Ching Yang; Dasheng Wang; Samuel K Kulp; Charles L Shapiro; Ching-Shih Chen
Journal:  J Biol Chem       Date:  2011-09-14       Impact factor: 5.157

6.  Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells.

Authors:  Q Meng; J Xu; I D Goldberg; E M Rosen; R A Greenwald; S Fan
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

7.  The expression of VE-cadherin in breast cancer cells modulates cell dynamics as a function of tumor differentiation and promotes tumor-endothelial cell interactions.

Authors:  Maryam Rezaei; Jiahui Cao; Katrin Friedrich; Björn Kemper; Oliver Brendel; Marianne Grosser; Manuela Adrian; Gustavo Baretton; Georg Breier; Hans-Joachim Schnittler
Journal:  Histochem Cell Biol       Date:  2017-11-15       Impact factor: 4.304

8.  Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells.

Authors:  W C Duivenvoorden; H W Hirte; G Singh
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

9.  Coexpression of carcinoembryonic antigen and E-cadherin in colorectal adenocarcinoma with liver metastasis.

Authors:  Jin C Kim; Seon A Roh; Hee C Kim; Kum H Koo; Young K Cho; Chang S Yu; Young M Kwon; Jung S Kim
Journal:  J Gastrointest Surg       Date:  2003-11       Impact factor: 3.452

10.  MDA-MB-435 human breast carcinoma metastasis to bone.

Authors:  John F Harms; Danny R Welch
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.